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Abstract
AIM: To evaluate the potential association between 
p53 codon 72 polymorphism and sporadic colorectal ad­
enocarcinoma development, and human papillomavirus 
(HPV) infection.
METHODS: One-hundred and nine controls and 53 pa­
tients with colon cancer from the city of La Plata, Argen­
tina were analyzed. p53 codon 72 genotypes and HPV 
infection were identified using allele-specific polymerase 
chain reaction and nested polymerase chain reaction, re­
spectively.
RESULTS: The differences in the distribution of/?55 co­
don 72 polymorphism between the cases and controls 
were statistically significant. The arginine allele had a 
prevalence of 0.65 in controls and 0.77 in cases. The 
corresponding odds ratio for the homozygous arginine 
genotype was 2.08 (95% CI, 1.06-4.05; P<0.05). Lack of 
association was found between p53 polymorphism and 
HPV infection in the set of adenocarcinomas.
CONCLUSION: The findings of the present study indi­
cate that p53 codon T1 arginine homozygous genotype 
may represent a genetic predisposing factor for colon 
cancer development. However, further studies are need­
ed in order to elucidate the role of p53 codon 72 poly­
morphism in colorectal cancer.
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Sporadic carcinoma of the colon and rectum is a common 
cause of cancer deaths in the more developed countries, 
accounting for 44/100 000 new cases per year in males 
from the LTnited States, and 33.1/100 000 in women. The 
incidence of colon cancer is lower in South America, rang­
ing from 16.4/100 000 in males and 14.8/100 000 in fe­
males. By contrast, Argentina has increased rates of colon 
cancer compared with other South American countries, 
which represents the second and the third cause of cancer 
deaths in women and men, respectively111.
Colorectal cancer development is a complex, gradual, 
multistep process, in which many factors are known to 
be implicated. The molecular and histological changes in­
volved are also well described, though not well understood. 
Most of these cancers are adenocarcinomas (95%), show­
ing a high frequency of p53 mutations, mainly at advanced 
stages of colorectal cancer progression1"1. Regarding the 
etiology, epidemiological studies have associated several 
risk factors with colorectal cancer, including alcohol con­
sumption, low-fiber or high-fat diet intake, hereditary 
conditions, familial history of colorectal cancer, personal 
history of colonic polyps and bowel inflammatory dis­
eases. Subjects with the highest risk for colorectal cancer 
have either a hereditary condition or a bowel inflammatory 
disease. However, it is worth mentioning that this group 
comprises only 6% of the general population, while the re­
maining of colorectal cancer occurs in individuals with no 
known risk factors131.
p53 is an important tumor suppressor gene involved 
in the regulation of cell growth, DNA maintenance and 
apoptosis. Also, experimental evidence suggests that the 
p53 protein is related to cell aggressiveness and tumor 
metastasis141. Recent studies have shown that a common 
polymorphism at codon 72 of the p53 gene results in two 
alleles, the arginine (A/v) and proline (Pro) isoforms, which 
differ biologically and biochemically151. In this sense, it ap­
pears that this polymorphism may be associated with dif­
ferential susceptibility to cancer. Several studies conducted 
in different countries reported significant associations
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Table 1 Genotype frequencies of p53 codon 72 polymorphism in colorectal controls and tumors according to Dukes staging
ArgZ4/y n (%)
Genotype frequencies
Arg/Pro n (%) Pro!Pro n (%)
Odds ratio 95% Cl
Controls 44 (40.3) 53 (48.6) 12(11.1) 1 (reference)
Carcinomas 31 (58.5) 20 (37.7) 2 (3.8) 2.08a 1.06-4.05
Dukes A-B 13 (52.0) 11 (44.0) 1 (4) 1.6 0.66-3.83
Dukes C-D 18 (64.3) 9 (32.1) 1 (3.6) 2.66a 1.12-6.29
•P<0.05.
between p53 polymorphism and human cancer. However, 
the data available for most cancers remain inconclusive, 
including for colorectal cancer16’101. In addition, the A/g 
isoform of the p53 protein was shown to be more suscep­
tible to degradation by the human papillomavirus (HPV) 
E6 protein than the proline one, and homozygosity for 
the arginine allele was found at higher frequency in the 
germlines of individuals affected by HPV-linked cancer1111. 
Although the presence of HPV-DNA in colorectal tissues 
and adenocarcinomas was reported in populations from 
different regions11"’161, the association of p53 codon 72 
polymorphism with colorectal cancer taking into account 
HPV infection was investigated only once[1?I. In order to 
elucidate the potential significance of p53 polymorphism 
in sporadic colorectal cancer, in association with high- 
risk HPV infection, a sample of 53 cases and 109 controls 
from tlie city of La Plata, Argentina was characterized, us­
ing PCR-based methods.
MATERIALS AND METHODS
Fifty-three patients with sporadic colorectal carcinomas 
and 109 healthy individuals were screened for p53 codon 
72 polymorphism variants. The age range for cases was 
51-80 years, and the age range for the controls was 18-67 
years. Colorectal adenocarcinomas were obtained from 
patients during surgical procedures. Liquid cytologies and 
gastrointestinal biopsies were taken from controls, consist­
ing of subjects with no evidence of neoplastic disorders. 
Specimens were classified according to the Dukes staging 
system, 7 as Dukes A, 18 as Dukes B, 19 as Dukes C and 9 
as Dukes D.
Paraffin embedded tissues were washed twice with xy­
lene and then with 100% ethanol, air-dried and suspended 
in 300 yl. of digestion buffer (Tris-HCL pH 8, Triton 
X-100 and Tween 20) with proteinase I< (100 pg/mL) for 
2 h at 56°C (Promega, Madison, Wisconsin, USA). Liq­
uid cytologies were suspended and washed twice with 1 
mL PBS, resuspended in 400 pL of digestion buffer and 
digested with proteinase I< for 2 h at 56°C. DNA was ex­
tracted from die lysates using the salting-out (salt precipita­
tion) procedure [18]. The samples were stored at —20°C until 
used.
p53 codon 12 polymorphism analysis
The p33 codon 72 polymorphism was studied using allele­
specific PCR, as previously described1111, with minor 
modifications1191. Detection of the amplicons was made 
by electrophoresis onto a 6% polyacrylamide minigel and 
ethidium bromide staining. Genotypes were finally deter­
mined under UV illumination.
Human papillomavirus detection and genotyping
HPV infection was investigated in colon tissues from 53 
patients. HPV DNA was detected by nested PCR, accord­
ing to the methods previously described1"01. The region 
LI of the viral genome was amplified, using MY09/11 as 
outer primers, and GP05/06 as inner primers. HPV geno­
typing was performed using the low ionic strength-single 
strand conformational polymorphism (LIS-SSCP) proce­
dure, as described elsewhere1"11. To determine DNA quality 
for PCR amplification, a fragment of the human thymidine 
kinase gene was amplified by PCR in all the samples1""1.
Statistical analysis
Association between p33 codon 72 genotypes, colorectal 
adenocarcinoma and HPV infection was assessed by the 
chi-square (/") test. The basic significance level was fixed at 
P < 0.05. The statistical analysis was performed using the 
statistical package SPSS™.
RESULTS
Histological classification of adenocarcinomas showed 
that 41.5% of tlie cases presented high differentiation, 
meanwhile 30.2% and 24.5% presented moderate and low 
differentiation, respectively. The remaining cases were un­
identified (3.8%). All DNA samples were successfully am­
plified by PCR for TI< gene, demonstrating that tlie DNA 
recovered from tlie paraffin embedded tissues had quality 
enough to be analyzed for gene polymorphisms and HPV 
infection. In control samples, tlie genotype distribution for 
p53 polymorphism showed 40.3%, 48.6% and 11.1% for 
tlie A/g/A/g, Arg/Pro and Pro/Pro genotypes, respectively. 
Allelic frequencies corresponded to 0.65 for die arginine 
allele and 0.35 for die proline allele. The obtained geno­
type frequencies fitted tlie Hardy-Weinberg equilibrium 
(P > 0.05). On die other hand, 58.5% of tlie cases were 
A/g/A/g, 37.7% were Arg/Pro and 3.8% were Pro/Pro. The 
corresponding frequencies were 0.77 for the arginine al­
lele and 0.23 for tlie proline allele. A significant difference 
between cases and controls was found for die Arg/Arg 
genotype compared with (grouped) Arg/Pro and Pro/Pro 
genotypes. Table 1 shows tlie obtained risk estimation for 
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colorectal cancer with its corresponding confidence inter­
vals.
HPV-DNA detection and genotyping was carried out 
using PCR-SSCP on a smaller set of adenocarcinomas 
(n — 53). HPV 16 was detected in 41.5% (22/53) of the 
tissues analyzed, HPV 18 in 24.5% (13/53) and HPV 33 in 
7.5%. The distribution of the p53 polymorphism in HPV 
negative samples was 53.8% (7/13) and 46.1% (6/13) for 
tlie Arg/Arg and Arg/Pro genotypes, respectively. None 
of tlie HPV negative samples tested positive for Pro/Pro. 
On the other hand, 60% (24/40) of tlie HPV positive 
samples were Arg/Arg, 35% (14/40) were Arg/Pro and 5% 
(2/40) were Pro/Pro. No significant differences were found 
between these two groups regarding Arg allele and HPV 
infection (OR, 1.28; 95% CI, 0.36-4.53; PXJ.05).
DISCUSSION
In this study, a positive correlation of p53 polymorphism 
and colorectal cancer was observed through analysis of a 
sample of 162 individuals from La Plata, Argentina. This 
observation is in agreement with the original study of 
Storey et al. (1998) on cervical cancer1111. However, tlie dis­
tribution of p53 genotypes according to type-specific HPV 
infections showed no significant association in tliis set of 
adenocarcinomas.
It is well known that tlie distribution of p53 codon 72 
polymorphism varies in different geographic regions and 
ethnicity. According to tlie literature, general populations 
from Latin America, United States and Europe exhibit 
high frequencies of tlie Arg allele compared to tlie Pro one, 
while lower prevalences of Arg are found in African and 
Asian populations l";’ "6|. In tliis study, tlie frequency for tlie 
arginine allele was estimated at 0.65. This result is concor­
dant with that obtained for tlie control group in a previous 
case-control study on cervical cancer performed in tlie city 
of La Plata1191.
The present study provides additional evidence re­
garding tlie role of both HPV infection andp53 codon 72 
variants in colon tissues. In agreement with previous stud­
ies, HPV-DNA was detected in a high proportion of ad­
enocarcinomas of tlie colon11"’16/ These findings may sug­
gest a potential role for high-risk HPV in colorectal cancer. 
Although tlie present study did not examine HPV DNA in 
normal colon tissues, its prevalence was reported in a case­
control study on colorectal cancer conducted in La Plata1161. 
Using PCR-based techniques, tlie authors found that 33% 
(10/30) of tlie normal samples were positive for HPV 
DNA. Interestingly, eighty percent (8/10) of tlie positives 
were single infections of HPV 16.
With respect to tliep53 polymorphism, tlie frequency 
of the Arg allele in colorectal cancer lesions showed a 
two-fold increase compared with that in normal samples. 
The estimated risk (OR) of tlie Arg/Arg genotype for 
colorectal cancer was 2.08, and subjects with Dukes C 
and D reported the highest frequency of Arg/Arg. This 
finding suggests that tlie Arg allele may be associated with 
increased malignancy in colorectal cancer progression. 
When stratified by HPV infection, tlie frequency of Arg/ 
Arg genotype in HPV positive adenocarcinomas was not 
statistically different from that in HPV negative samples. 
However, it should be considered that this finding may 
represent an artifact, possibly produced as a result of tlie 
small sample size.
Case and control studies conducted in Japan and Tur­
key failed to find an association between die prevalence 
of p53 polymorphism and colorectal cancer16'17/ In the 
study conducted by Murata et al. (1996), tlie allelic frequen­
cies were concordant between die controls and two sets 
of colorectal and lung cancer cases, reaching a frequency 
of approximately 0.6 for die Arg allele. The authors only 
found a significant association betweenp53 polymorphism 
and lung cancer in non-smoking patients16/ Similar to our 
study, Sayhan et al. (2001) incorporated the analysis of 
HPV infection in a case-control study on colorectal cancer 
andp53 codon 72 polymorphism. However,p53 genotypes 
did not correlate with colon cancer, or with tlie prevalence 
of high-risk HPV infections117/ On tlie other hand, a case­
control study conducted in Spain showed a modest asso­
ciation between die Pro allele and colorectal cancer (OR, 
1.34; P — 0.066). However, such an association was of 
borderline significance, and it was lost when die analysis 
was adjusted to another common polymorphism of p53 
examined in that study, /¡55PIN3110/
The present study has several strengths, including die 
use of a representative group of controls from die city of 
La Plata and die careful examination of all stages of co­
lon cancer. Regarding methodology, misclassification and 
allelic loss was avoided by die use of two separate allele­
specific PCR reactions, so that low copies of one allele 
would not be affected by die presence of several copies of 
the other. On die other hand, die present study was not 
controlled for other potential predisposing factors, such as 
smoking or life-style habits. This is an important issue to 
be addressed in further studies in order to assess die role 
of p53 polymorphism in tliis tissue.
The mechanisms which lead to the increase of the 
Arg allele in human cancers are not well-established. An­
other mechanism proposed to explain die epidemiological 
findings was postulated by Marin et al. (2000)1"7/ In their 
study, die authors demonstrated that certain conforma­
tional p53 mutants bind and inactivate the p73 protein, 
a p53 homologue and transcription factor of some p53 
target genes1"8/ In experimental assays, the binding of 
the p53 Arg isoform to p73 equaled to or exceeded that 
promoted by die corresponding Pro isoform. Thus, it ap­
pears that die p53 codon 72 polymorphism influences die 
interaction between p53 mutants and p73, and therefore 
its ability to activate some p53 target genes. In tliis sense, 
preferential mutation and retention of die Arg allele was 
found in a set of various cell cancers from p53 codon 72 
germline heterozygotes1"7/ However, a recent study did not 
find that p53-p73 beta interactions were influenced by die 
p53 polymorphism1"9/ Moreover, no significant differences 
were found in p53 mutation prevalence between Arg/Arg 
(40/97) and Pro/Pro (7/16) genotypes in a set of colorectal 
tumors17/ These contradictory findings implicate that tlie 
involvement of p53 polymorphism in human cancer de­
mands further study. More recently, Schneider-Stock et al. 
(2004) found preferential mutation of die Arg allele in a 
group of colorectal adenocarcinomas. They also reported 
selective loss of die Pro allele in tumors with loss of het­
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erozygosity (LOH), resulting in a positive association be­
tween Arg prevalence and Dukes progression. The authors 
discarded the possibility of HPV as a potential mechanism 
for the higher frequency of Arg alleles in colorectal tumors 
and hypothesized that carcinogenic exposure may selec­
tively affect thep53 Pro allele in the development of colon
[8] cancer .
Overall, the findings of the present study indicate that 
the p53 codon 72 polymorphism may act as a predispos­
ing factor to colorectal cancer but it is not associated with 
high-nsk HPV infections. Clearly, the data available are still 
inconsistent and it would be unwise to draw conclusions. 
Further studies of larger sample sizes, including the analy­
sis of the premalignant lesions and the status of the p53 
gene, are awaited in order to elucidate the magnitude of 
genetic susceptibility in sporadic colorectal carcinogenesis.
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